Dose-Ranging Study to Assess the Safety and Efficacy of Melatonin in Outpatients Infected With COVID-19

NCT04784754 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped lack of subject enrollment

Conditions

COVID-19

Interventions

DRUG: Melatonin
DRUG: Placebo

Sponsor

State University of New York at Buffalo

Collaborators

[object Object]